This study focuses on China’s Mental Illness Drugs industry forecasts.
In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.
The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2009, 2014 and 2019) and long-term forecasts through 2024 and 2029 are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Our reports have been used by over 10K customers, including:
Mania Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Mania Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mania Clinical trials scenario.This report provides top line data relating to the clinical trials on Mania. Report includes...
"US Alzheimer’s Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • US Alzheimer’s Disease Drug Market Opportunity: > US$ 5 Billion • US Accounts For More Than 40% of Global Alzheimer’s Disease Drug Market • US Alzheimer’s Disease Drug Clinical Trials: 200 Drugs in Pipeline •...
Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Central...
Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with...
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transdermal Drug Delivery Devicess pipeline products with...
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 Summary 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 13 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes....
214 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports &...
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Research Report by Diagnostic Test (Bone Marrow Examination, Complete Blood Count Test (CBC), Flow Cytometry, Lactate Dehydrogenase Test (LDH), and Urine Test for Hemosiderin), by Treatment (Blood Transfusion, Medication, and Stem Cell Transplant) - Global Forecast to 2025...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.